Eisenberg, Elisheva R.
Weiss, Anna
Prakash, Ipshita
Skamene, Sonia
Basik, Mark
Boileau, Jean Francois
Ajjamada, Lissa
Pollak, Michael N.
Wong, Stephanie M.
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé (309854)
Article History
Received: 28 February 2022
Accepted: 12 May 2022
First Online: 6 June 2022
Disclosures
: Lissa Ajjamada reports research funding from Incyte pharmaceuticals and honoraria from Merck, and Bristol Myers Squibb outside the submitted work. Anna Weiss reports research funding from Myriad Laboratories, Inc. outside the submitted work. Jean-Francois Boileau reports honoraria from Roche, Novartis, Genomic Health, Pfizer, Allergan, and Merck; personal fees from Roche, Genomic Health, NanoString Technologies, Pfizer, Eli Lilly, Novartis, and Merck; and travel support from Roche, GlaxoSmithKline, Novartis, Pfizer, and Lifecell outside the submitted work. The remaining authors have no conflicts of interest to disclose.